NZ532261A - Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis - Google Patents

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Info

Publication number
NZ532261A
NZ532261A NZ532261A NZ53226102A NZ532261A NZ 532261 A NZ532261 A NZ 532261A NZ 532261 A NZ532261 A NZ 532261A NZ 53226102 A NZ53226102 A NZ 53226102A NZ 532261 A NZ532261 A NZ 532261A
Authority
NZ
New Zealand
Prior art keywords
hydroxy
pct
compounds
iii
methyl
Prior art date
Application number
NZ532261A
Other languages
English (en)
Inventor
Peter G Milner
Jurg R Pfister
Pascal Druzgala
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/961,538 external-priority patent/US6784199B2/en
Priority claimed from US09/961,542 external-priority patent/US6768008B2/en
Priority claimed from US10/228,670 external-priority patent/US20030054974A1/en
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Publication of NZ532261A publication Critical patent/NZ532261A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ532261A 2001-09-21 2002-09-20 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis NZ532261A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/961,538 US6784199B2 (en) 2000-09-21 2001-09-21 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US09/961,542 US6768008B2 (en) 2000-04-24 2001-09-21 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US10/228,670 US20030054974A1 (en) 2001-08-24 2002-08-26 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
PCT/US2002/030017 WO2003024943A2 (en) 2000-04-24 2002-09-20 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis

Publications (1)

Publication Number Publication Date
NZ532261A true NZ532261A (en) 2006-02-24

Family

ID=49447234

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ532261A NZ532261A (en) 2001-09-21 2002-09-20 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Country Status (5)

Country Link
EP (1) EP1430039A2 (ja)
JP (1) JP2005527475A (ja)
KR (1) KR20040062545A (ja)
CA (1) CA2460150A1 (ja)
NZ (1) NZ532261A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100829468B1 (ko) * 2007-01-17 2008-05-16 한국화학연구원 신규한 1,2,4-티아다이아졸리딘-3,5-다이온 화합물 및 이의제조방법

Also Published As

Publication number Publication date
EP1430039A2 (en) 2004-06-23
JP2005527475A (ja) 2005-09-15
KR20040062545A (ko) 2004-07-07
CA2460150A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
EP1424330B1 (en) Activator for peroxisome proliferator-responsive receptor delta
US6768008B2 (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US4725610A (en) Thiazolidinedione derivatives, their production and use
KR101539308B1 (ko) 당뇨병 및 대사 장애의 치료를 위한 헤테로시클릭 수용체 작용제
JP2000514041A (ja) 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物
EP0971917B1 (en) Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
JP2005529077A (ja) ペルオキシソーム増殖因子活性化受容体調節物質
CZ216398A3 (cs) Sloučenina mající aktivitu agonisty PPAR-alfa a PPAR-gama, takový agonista a jeho použití, farmaceutický prostředek s jeho obsahem a způsob detekce
JP2000507216A (ja) ＰＰＡＲ―γに対するアゴニスト活性を有する置換４―ヒドロキシフェニルアルカン酸誘導体
JPH10194971A (ja) 置換チアゾリジンジオン誘導体を含む抗高血圧剤
HRP20010095A2 (en) SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS
Kees et al. Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db mice
US6011036A (en) Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
US6784199B2 (en) Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US6680387B2 (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
RU2296759C2 (ru) N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
JP5414280B2 (ja) 新規複素環式ジフェニルエーテル
AU2001259130A1 (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6958355B2 (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
WO2006117743A1 (en) Substituted aromatic compounds as antidiabetic agents
NZ532261A (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US20060047000A1 (en) Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2002327683A1 (en) Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
ZA200401945B (en) Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis.
Shinkai et al. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)